Unresectable Dedifferentiated Liposarcoma
specificDedifferentiated liposarcoma that is not amenable to surgical resection.
64
Centers
83
Active Trials
—
Cancer Funding
Top Centers for Unresectable Dedifferentiated Liposarcoma(64)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 70.5 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center | 70.5 |
| 3 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive High-Volume Research Center | 70.5 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive High-Volume Research Center | 70.5 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive High-Volume Research Center | 70.5 |
| 6 | University of Illinois Cancer CenterChicago, IL High-Volume Research Center | 70.5 |
| 7 | Boston University Cancer CenterBoston, MA High-Volume Research Center | 70.5 |
| 8 | Cancer Center at IllinoisUrbana, IL High-Volume Research Center | 70.5 |
| 9 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 62.0 |
| 10 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 62.0 |
| 11 | NCI Comprehensive Active Research Program | 62.0 |
| 12 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 62.0 |
| 13 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 62.0 |
| 14 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 62.0 |
| 15 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 62.0 |
| 16 | NCI Clinical Active Research Program | 62.0 |
| 17 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 62.0 |
| 18 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 62.0 |
| 19 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 62.0 |
| 20 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 62.0 |
| 21 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 62.0 |
| 22 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 62.0 |
| 23 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 62.0 |
| 24 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 62.0 |
| 25 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 46.9 |
| 26 | NCI Comprehensive Active Research Program | 46.9 |
| 27 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 46.9 |
| 28 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 46.9 |
| 29 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 46.9 |
| 30 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 46.9 |
| 31 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 46.9 |
| 32 | NCI Comprehensive Active Research Program | 46.9 |
| 33 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 46.9 |
| 34 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 46.9 |
| 35 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 46.9 |
| 36 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 46.9 |
| 37 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 46.9 |
| 38 | NCI Comprehensive Active Research Program | 46.9 |
| 39 | NCI Comprehensive Active Research Program | 46.9 |
| 40 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 46.9 |
| 41 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 46.9 |
| 42 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 46.9 |
| 43 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 46.9 |
| 44 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 46.9 |
| 45 | Active Research Program | 46.9 |
| 46 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 46.9 |
| 47 | UofL James Graham Brown Cancer CenterLouisville, KY Active Research Program | 46.9 |
| 48 | Active Research Program | 46.9 |
| 49 | Northwell Health Cancer InstituteNew York, NY Active Research Program | 46.9 |
| 50 | Active Research Program | 46.9 |
| 51 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 46.9 |
| 52 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive | 32.9 |
| 53 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive | 32.9 |
| 54 | NCI Comprehensive | 32.9 |
| 55 | Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive | 32.9 |
| 56 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive | 32.9 |
| 57 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive | 32.9 |
| 58 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR | 32.9 |
| 59 | The Jackson Laboratory Cancer CenterBar Harbor, ME NCI Basic_laboratory | 32.9 |
| 60 | The University of Vermont Cancer CenterBurlington, VT | 32.9 |
| 61 | Upstate Cancer CenterSyracuse, NY | 32.9 |
| 62 | University of Texas Medical Branch Cancer CenterGalveston, TX | 32.9 |
| 63 | Loma Linda University Cancer CenterLoma Linda, CA | 32.9 |
| 64 | Louisiana Cancer Research CenterNew Orleans, LA | 32.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →